Concepedia

Yuichiro Iwamoto

YI

Statistics

Publications

13

Citations

474

H-Index

11

Active since

1997

Affiliations

Kawasaki Medical School(Current)

Osaka City General Hospital

Yokohama City University

Nagoya Medical Center

National Hospital Organization

Yuichiro Iwamoto is an author at Kawasaki Medical School specializing in oncology, medicine, and chemotherapy.

ORCID

Publications per year

1997–2024

13

Publications

13

A multicenter phase II study of carboplatin and paclitaxel for advanced thymic carcinoma: WJOG4207L

Fumihiko Hirai, Takeharu Yamanaka, Kenichi Taguchi et al. · Annals of Oncology · 2014 · 130 citations · Full text

, , +5

Open-label phase II study of the efficacy of nivolumab for cancer of unknown primary

Junko Tanizaki, Kan Yonemori, Kohei Akiyoshi et al. · Annals of Oncology · 2021 · 73 citations · Full text

, , +17

Efficacy and safety analysis according to histology for S-1 in combination with carboplatin as first-line chemotherapy in patients with advanced non-small-cell lung cancer: updated results of the West Japan Oncology Group LETS study

Hiroshige Yoshioka, Isamu Okamoto, Satoshi Morita et al. · Annals of Oncology · 2013 · 59 citations

, , +12

Cytokeratin subtyping in chordomas and the fetal notochord: an immunohistochemical analysis of aberrant expression.

T Naka, Yuichiro Iwamoto, Norio Shinohara et al. · PubMed · 1997 · 55 citations

, , +10

Randomized phase III trial comparing weekly docetaxel (D)-cisplatin (P) combination with triweekly D alone in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC): An intergroup trial of JCOG0803/WJOG4307L.

Takashige Abe, Akira Yokoyama, Koji Takeda et al. · Journal of Clinical Oncology · 2011 · 39 citations

, , +11

1–5 of 13